These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 346366)

  • 21. Use of 6-hydroxydopamine to create lesions in catecholamine neurons in rats.
    Mendez JS; Finn BW
    J Neurosurg; 1975 Feb; 42(2):166-73. PubMed ID: 234524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deficits in instrumental responding after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection.
    Fibiger HC; Phillips AG; Zis AP
    Pharmacol Biochem Behav; 1974; 2(1):87-96. PubMed ID: 4151316
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cerebral amines and behavior. Central effects of 6-hydroxydopamine].
    Longo VG; Scotti de Carolis A
    Actual Pharmacol (Paris); 1973; 26(0):103-19. PubMed ID: 4367113
    [No Abstract]   [Full Text] [Related]  

  • 24. Attenuation of amphetamine-induced motor stimulation and stereotypy by 6-hydroxydopamine in the rat.
    Fibiger HC; Fibiger HP; Zis AP
    Br J Pharmacol; 1973 Apr; 47(4):683-92. PubMed ID: 4146741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological investigation of rotational behaviors produced by unilateral electrical stimulation of the substantia nigra in the rat].
    Watanabe H; Hata S; Watanabe K
    Nihon Yakurigaku Zasshi; 1983 Oct; 82(4):247-57. PubMed ID: 6141127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral changes in 6-hydroxydopamine-treated rotation rats after delivery of various neuromodifying agents by means of a stereotactically implanted pellet to the brain.
    Yoshida M; Torigoe R; Ohtsuru K; Kuramoto S
    Stereotact Funct Neurosurg; 1990; 54-55():342-6. PubMed ID: 2127860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conditioned rotational behavior in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra.
    Carey RJ
    Brain Res; 1986 Feb; 365(2):379-82. PubMed ID: 3081236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical changes accompanying unilateral 6-hydroxydopamine lesions in the rat substantia nigra.
    Saavedra JM; Setler PE; Kebabian JW
    Brain Res; 1978 Aug; 151(2):339-52. PubMed ID: 679013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral effects of direct- and indirect-acting dopaminergic agonists.
    Moore KE
    Adv Biochem Psychopharmacol; 1974; 12(0):403-14. PubMed ID: 4371765
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus.
    Cooper BR; Konkol RJ; Breese GR
    J Pharmacol Exp Ther; 1978 Mar; 204(3):592-605. PubMed ID: 24729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Injection of 6-hydroxydopamine into the substantia nigra of the rat. II. Diffusion and specificity.
    Agid Y; Javoy F; Glowinski J; Bouvet D; Sotelo C
    Brain Res; 1973 Aug; 58(2):291-301. PubMed ID: 4756131
    [No Abstract]   [Full Text] [Related]  

  • 32. Sensitization to stress: the enduring effects of prior stress on amphetamine-induced rotational behavior.
    Robinson TE; Angus AL; Becker JB
    Life Sci; 1985 Sep; 37(11):1039-42. PubMed ID: 4041000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that punctate intracerebral administration of 6-hydroxydopamine fails to produce selective neuronal degeneration. Comparison with copper sulfate and factors governing the deportment of fluids injected into brain.
    Butcher LL; Eastgate SM; Hodge GK
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(1):31-70. PubMed ID: 4155050
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of intracerebroventricular injection of 6-hydroxydopamine and 5,6-dyhydroxytryptamine on the phasic secretion of luteinizing hormone (author's transl)].
    Montilla P; Muñoz M; Palacios JL
    Rev Esp Fisiol; 1979 Jun; 35(2):163-8. PubMed ID: 482718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of 6-hydroxydopamine or 5,7-dihydroxy-tryptamine on the development of physical dependence on ethanol.
    Frye GD; Ellis FW
    Drug Alcohol Depend; 1977; 2(5-6):349-59. PubMed ID: 562250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.
    Hudson JL; van Horne CG; Strömberg I; Brock S; Clayton J; Masserano J; Hoffer BJ; Gerhardt GA
    Brain Res; 1993 Oct; 626(1-2):167-74. PubMed ID: 8281427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B; Naylor RJ; Pycock C
    Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacological and anatomical substrates of the amphetamine response in the rat.
    Creese I; Iversen SD
    Brain Res; 1975 Jan; 83(3):419-36. PubMed ID: 234270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tail temperature in rats after intraventricular injections of 6-hydroxydopamine or 5,7-dihydroxytryptamine.
    Ishikawa Y; Matuszek M; Nakayama T
    Neurosci Lett; 1980 Nov; 20(2):177-81. PubMed ID: 7443067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS; Fine A; Robertson HA
    Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.